Multiplex plasma protein profiling identifies novel markers to discriminate patients with adenocarcinoma of the lung

BACKGROUND: The overall prognosis of non-small cell lung cancer (NSCLC) is poor, and currently only patients with localized disease are potentially curable. Therefore, preferably non-invasively determined biomarkers that detect NSCLC patients at early stages of the disease are of high clinical relev...

Descripción completa

Detalles Bibliográficos
Autores principales: Djureinovic, Dijana, Pontén, Victor, Landelius, Per, Al Sayegh, Sahar, Kappert, Kai, Kamali-Moghaddam, Masood, Micke, Patrick, Ståhle, Elisabeth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6664554/
https://www.ncbi.nlm.nih.gov/pubmed/31357969
http://dx.doi.org/10.1186/s12885-019-5943-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6664554/
https://www.ncbi.nlm.nih.gov/pubmed/31357969
http://dx.doi.org/10.1186/s12885-019-5943-3

Ejemplares similares